The Market Reports

Index

1 Market Overview
1.1 Product Overview and Scope of β2 Adrenoceptor Agonists
1.2 Classification of β2 Adrenoceptor Agonists by Type
1.2.1 Overview: Global β2 Adrenoceptor Agonists Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global β2 Adrenoceptor Agonists Revenue Market Share by Type in 2021
1.2.3 Albuterol
1.2.4 Terbutaline
1.2.5 Salmeterol
1.2.6 Formoterol
1.2.7 Pirbuterol
1.3 Global β2 Adrenoceptor Agonists Market by Application
1.3.1 Overview: Global β2 Adrenoceptor Agonists Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Bronchial Asthma
1.3.3 Asthmatic Bronchitis
1.3.4 Emphysema
1.3.5 Others
1.4 Global β2 Adrenoceptor Agonists Market Size & Forecast
1.5 Global β2 Adrenoceptor Agonists Market Size and Forecast by Region
1.5.1 Global β2 Adrenoceptor Agonists Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global β2 Adrenoceptor Agonists Market Size by Region, (2017-2022)
1.5.3 North America β2 Adrenoceptor Agonists Market Size and Prospect (2017-2028)
1.5.4 Europe β2 Adrenoceptor Agonists Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific β2 Adrenoceptor Agonists Market Size and Prospect (2017-2028)
1.5.6 South America β2 Adrenoceptor Agonists Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa β2 Adrenoceptor Agonists Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 β2 Adrenoceptor Agonists Market Drivers
1.6.2 β2 Adrenoceptor Agonists Market Restraints
1.6.3 β2 Adrenoceptor Agonists Trends Analysis
2 Company Profiles
2.1 Ivax Pharmaceuticals 
2.1.1 Ivax Pharmaceuticals  Details
2.1.2 Ivax Pharmaceuticals  Major Business
2.1.3 Ivax Pharmaceuticals  β2 Adrenoceptor Agonists Product and Solutions
2.1.4 Ivax Pharmaceuticals  β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Ivax Pharmaceuticals  Recent Developments and Future Plans
2.2 Physicians Total Care
2.2.1 Physicians Total Care Details
2.2.2 Physicians Total Care Major Business
2.2.3 Physicians Total Care β2 Adrenoceptor Agonists Product and Solutions
2.2.4 Physicians Total Care β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Physicians Total Care Recent Developments and Future Plans
2.3 Baxter Healthcare 
2.3.1 Baxter Healthcare  Details
2.3.2 Baxter Healthcare  Major Business
2.3.3 Baxter Healthcare  β2 Adrenoceptor Agonists Product and Solutions
2.3.4 Baxter Healthcare  β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Baxter Healthcare  Recent Developments and Future Plans
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi β2 Adrenoceptor Agonists Product and Solutions
2.4.4 Sanofi β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Sanofi Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer β2 Adrenoceptor Agonists Product and Solutions
2.5.4 Pfizer β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Pfizer Recent Developments and Future Plans
2.6 Bedford Laboratories
2.6.1 Bedford Laboratories Details
2.6.2 Bedford Laboratories Major Business
2.6.3 Bedford Laboratories β2 Adrenoceptor Agonists Product and Solutions
2.6.4 Bedford Laboratories β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Bedford Laboratories Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis β2 Adrenoceptor Agonists Product and Solutions
2.7.4 Novartis β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Novartis Recent Developments and Future Plans
2.8 Sterimax
2.8.1 Sterimax Details
2.8.2 Sterimax Major Business
2.8.3 Sterimax β2 Adrenoceptor Agonists Product and Solutions
2.8.4 Sterimax β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Sterimax Recent Developments and Future Plans
2.9 Teligent
2.9.1 Teligent Details
2.9.2 Teligent Major Business
2.9.3 Teligent β2 Adrenoceptor Agonists Product and Solutions
2.9.4 Teligent β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Teligent Recent Developments and Future Plans
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business
2.10.3 AstraZeneca β2 Adrenoceptor Agonists Product and Solutions
2.10.4 AstraZeneca β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 AstraZeneca Recent Developments and Future Plans
2.11 Hikma Pharmaceuticals
2.11.1 Hikma Pharmaceuticals Details
2.11.2 Hikma Pharmaceuticals Major Business
2.11.3 Hikma Pharmaceuticals β2 Adrenoceptor Agonists Product and Solutions
2.11.4 Hikma Pharmaceuticals β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Hikma Pharmaceuticals Recent Developments and Future Plans
2.12 Av Kare
2.12.1 Av Kare Details
2.12.2 Av Kare Major Business
2.12.3 Av Kare β2 Adrenoceptor Agonists Product and Solutions
2.12.4 Av Kare β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Av Kare Recent Developments and Future Plans
2.13 Impax Laboratories
2.13.1 Impax Laboratories Details
2.13.2 Impax Laboratories Major Business
2.13.3 Impax Laboratories β2 Adrenoceptor Agonists Product and Solutions
2.13.4 Impax Laboratories β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Impax Laboratories Recent Developments and Future Plans
2.14 PD-Rx Pharmaceuticals
2.14.1 PD-Rx Pharmaceuticals Details
2.14.2 PD-Rx Pharmaceuticals Major Business
2.14.3 PD-Rx Pharmaceuticals β2 Adrenoceptor Agonists Product and Solutions
2.14.4 PD-Rx Pharmaceuticals β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 PD-Rx Pharmaceuticals Recent Developments and Future Plans
2.15 Athenex Pharmaceutical Division
2.15.1 Athenex Pharmaceutical Division Details
2.15.2 Athenex Pharmaceutical Division Major Business
2.15.3 Athenex Pharmaceutical Division β2 Adrenoceptor Agonists Product and Solutions
2.15.4 Athenex Pharmaceutical Division β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Athenex Pharmaceutical Division Recent Developments and Future Plans
2.16 Teva
2.16.1 Teva Details
2.16.2 Teva Major Business
2.16.3 Teva β2 Adrenoceptor Agonists Product and Solutions
2.16.4 Teva β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Teva Recent Developments and Future Plans
2.17 Marlex Pharmaceuticals
2.17.1 Marlex Pharmaceuticals Details
2.17.2 Marlex Pharmaceuticals Major Business
2.17.3 Marlex Pharmaceuticals β2 Adrenoceptor Agonists Product and Solutions
2.17.4 Marlex Pharmaceuticals β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Marlex Pharmaceuticals Recent Developments and Future Plans
2.18 Lannett Company
2.18.1 Lannett Company Details
2.18.2 Lannett Company Major Business
2.18.3 Lannett Company β2 Adrenoceptor Agonists Product and Solutions
2.18.4 Lannett Company β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Lannett Company Recent Developments and Future Plans
2.19 West-Ward Pharmaceuticals
2.19.1 West-Ward Pharmaceuticals Details
2.19.2 West-Ward Pharmaceuticals Major Business
2.19.3 West-Ward Pharmaceuticals β2 Adrenoceptor Agonists Product and Solutions
2.19.4 West-Ward Pharmaceuticals β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 West-Ward Pharmaceuticals Recent Developments and Future Plans
2.20 United Biomedical
2.20.1 United Biomedical Details
2.20.2 United Biomedical Major Business
2.20.3 United Biomedical β2 Adrenoceptor Agonists Product and Solutions
2.20.4 United Biomedical β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20.5 United Biomedical Recent Developments and Future Plans
2.21 Merck
2.21.1 Merck Details
2.21.2 Merck Major Business
2.21.3 Merck β2 Adrenoceptor Agonists Product and Solutions
2.21.4 Merck β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21.5 Merck Recent Developments and Future Plans
2.22 Mylan
2.22.1 Mylan Details
2.22.2 Mylan Major Business
2.22.3 Mylan β2 Adrenoceptor Agonists Product and Solutions
2.22.4 Mylan β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22.5 Mylan Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global β2 Adrenoceptor Agonists Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 β2 Adrenoceptor Agonists Players Market Share in 2021
3.2.2 Top 10 β2 Adrenoceptor Agonists Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 β2 Adrenoceptor Agonists Players Head Office, Products and Services Provided
3.4 β2 Adrenoceptor Agonists Mergers & Acquisitions
3.5 β2 Adrenoceptor Agonists New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global β2 Adrenoceptor Agonists Revenue and Market Share by Type (2017-2022)
4.2 Global β2 Adrenoceptor Agonists Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global β2 Adrenoceptor Agonists Revenue Market Share by Application (2017-2022)
5.2 Global β2 Adrenoceptor Agonists Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America β2 Adrenoceptor Agonists Revenue by Type (2017-2028)
6.2 North America β2 Adrenoceptor Agonists Revenue by Application (2017-2028)
6.3 North America β2 Adrenoceptor Agonists Market Size by Country
6.3.1 North America β2 Adrenoceptor Agonists Revenue by Country (2017-2028)
6.3.2 United States β2 Adrenoceptor Agonists Market Size and Forecast (2017-2028)
6.3.3 Canada β2 Adrenoceptor Agonists Market Size and Forecast (2017-2028)
6.3.4 Mexico β2 Adrenoceptor Agonists Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe β2 Adrenoceptor Agonists Revenue by Type (2017-2028)
7.2 Europe β2 Adrenoceptor Agonists Revenue by Application (2017-2028)
7.3 Europe β2 Adrenoceptor Agonists Market Size by Country
7.3.1 Europe β2 Adrenoceptor Agonists Revenue by Country (2017-2028)
7.3.2 Germany β2 Adrenoceptor Agonists Market Size and Forecast (2017-2028)
7.3.3 France β2 Adrenoceptor Agonists Market Size and Forecast (2017-2028)
7.3.4 United Kingdom β2 Adrenoceptor Agonists Market Size and Forecast (2017-2028)
7.3.5 Russia β2 Adrenoceptor Agonists Market Size and Forecast (2017-2028)
7.3.6 Italy β2 Adrenoceptor Agonists Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific β2 Adrenoceptor Agonists Revenue by Type (2017-2028)
8.2 Asia-Pacific β2 Adrenoceptor Agonists Revenue by Application (2017-2028)
8.3 Asia-Pacific β2 Adrenoceptor Agonists Market Size by Region
8.3.1 Asia-Pacific β2 Adrenoceptor Agonists Revenue by Region (2017-2028)
8.3.2 China β2 Adrenoceptor Agonists Market Size and Forecast (2017-2028)
8.3.3 Japan β2 Adrenoceptor Agonists Market Size and Forecast (2017-2028)
8.3.4 South Korea β2 Adrenoceptor Agonists Market Size and Forecast (2017-2028)
8.3.5 India β2 Adrenoceptor Agonists Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia β2 Adrenoceptor Agonists Market Size and Forecast (2017-2028)
8.3.7 Australia β2 Adrenoceptor Agonists Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America β2 Adrenoceptor Agonists Revenue by Type (2017-2028)
9.2 South America β2 Adrenoceptor Agonists Revenue by Application (2017-2028)
9.3 South America β2 Adrenoceptor Agonists Market Size by Country
9.3.1 South America β2 Adrenoceptor Agonists Revenue by Country (2017-2028)
9.3.2 Brazil β2 Adrenoceptor Agonists Market Size and Forecast (2017-2028)
9.3.3 Argentina β2 Adrenoceptor Agonists Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa β2 Adrenoceptor Agonists Revenue by Type (2017-2028)
10.2 Middle East & Africa β2 Adrenoceptor Agonists Revenue by Application (2017-2028)
10.3 Middle East & Africa β2 Adrenoceptor Agonists Market Size by Country
10.3.1 Middle East & Africa β2 Adrenoceptor Agonists Revenue by Country (2017-2028)
10.3.2 Turkey β2 Adrenoceptor Agonists Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia β2 Adrenoceptor Agonists Market Size and Forecast (2017-2028)
10.3.4 UAE β2 Adrenoceptor Agonists Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables

List of Tables
Table 1. Global β2 Adrenoceptor Agonists Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global β2 Adrenoceptor Agonists Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market β2 Adrenoceptor Agonists Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global β2 Adrenoceptor Agonists Revenue (USD Million) by Region (2017-2022)
Table 5. Global β2 Adrenoceptor Agonists Revenue Market Share by Region (2023-2028)
Table 6. Ivax Pharmaceuticals  Corporate Information, Head Office, and Major Competitors
Table 7. Ivax Pharmaceuticals  Major Business
Table 8. Ivax Pharmaceuticals  β2 Adrenoceptor Agonists Product and Solutions
Table 9. Ivax Pharmaceuticals  β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Physicians Total Care Corporate Information, Head Office, and Major Competitors
Table 11. Physicians Total Care Major Business
Table 12. Physicians Total Care β2 Adrenoceptor Agonists Product and Solutions
Table 13. Physicians Total Care β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Baxter Healthcare  Corporate Information, Head Office, and Major Competitors
Table 15. Baxter Healthcare  Major Business
Table 16. Baxter Healthcare  β2 Adrenoceptor Agonists Product and Solutions
Table 17. Baxter Healthcare  β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Sanofi Corporate Information, Head Office, and Major Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi β2 Adrenoceptor Agonists Product and Solutions
Table 21. Sanofi β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Pfizer Corporate Information, Head Office, and Major Competitors
Table 23. Pfizer Major Business
Table 24. Pfizer β2 Adrenoceptor Agonists Product and Solutions
Table 25. Pfizer β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Bedford Laboratories Corporate Information, Head Office, and Major Competitors
Table 27. Bedford Laboratories Major Business
Table 28. Bedford Laboratories β2 Adrenoceptor Agonists Product and Solutions
Table 29. Bedford Laboratories β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Novartis Corporate Information, Head Office, and Major Competitors
Table 31. Novartis Major Business
Table 32. Novartis β2 Adrenoceptor Agonists Product and Solutions
Table 33. Novartis β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Sterimax Corporate Information, Head Office, and Major Competitors
Table 35. Sterimax Major Business
Table 36. Sterimax β2 Adrenoceptor Agonists Product and Solutions
Table 37. Sterimax β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Teligent Corporate Information, Head Office, and Major Competitors
Table 39. Teligent Major Business
Table 40. Teligent β2 Adrenoceptor Agonists Product and Solutions
Table 41. Teligent β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 43. AstraZeneca Major Business
Table 44. AstraZeneca β2 Adrenoceptor Agonists Product and Solutions
Table 45. AstraZeneca β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Hikma Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 47. Hikma Pharmaceuticals Major Business
Table 48. Hikma Pharmaceuticals β2 Adrenoceptor Agonists Product and Solutions
Table 49. Hikma Pharmaceuticals β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Av Kare Corporate Information, Head Office, and Major Competitors
Table 51. Av Kare Major Business
Table 52. Av Kare β2 Adrenoceptor Agonists Product and Solutions
Table 53. Av Kare β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Impax Laboratories Corporate Information, Head Office, and Major Competitors
Table 55. Impax Laboratories Major Business
Table 56. Impax Laboratories β2 Adrenoceptor Agonists Product and Solutions
Table 57. Impax Laboratories β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. PD-Rx Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 59. PD-Rx Pharmaceuticals Major Business
Table 60. PD-Rx Pharmaceuticals β2 Adrenoceptor Agonists Product and Solutions
Table 61. PD-Rx Pharmaceuticals β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Athenex Pharmaceutical Division Corporate Information, Head Office, and Major Competitors
Table 63. Athenex Pharmaceutical Division Major Business
Table 64. Athenex Pharmaceutical Division β2 Adrenoceptor Agonists Product and Solutions
Table 65. Athenex Pharmaceutical Division β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Teva Corporate Information, Head Office, and Major Competitors
Table 67. Teva Major Business
Table 68. Teva β2 Adrenoceptor Agonists Product and Solutions
Table 69. Teva β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Marlex Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 71. Marlex Pharmaceuticals Major Business
Table 72. Marlex Pharmaceuticals β2 Adrenoceptor Agonists Product and Solutions
Table 73. Marlex Pharmaceuticals β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Lannett Company Corporate Information, Head Office, and Major Competitors
Table 75. Lannett Company Major Business
Table 76. Lannett Company β2 Adrenoceptor Agonists Product and Solutions
Table 77. Lannett Company β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. West-Ward Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 79. West-Ward Pharmaceuticals Major Business
Table 80. West-Ward Pharmaceuticals β2 Adrenoceptor Agonists Product and Solutions
Table 81. West-Ward Pharmaceuticals β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. United Biomedical Corporate Information, Head Office, and Major Competitors
Table 83. United Biomedical Major Business
Table 84. United Biomedical β2 Adrenoceptor Agonists Product and Solutions
Table 85. United Biomedical β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 86. Merck Corporate Information, Head Office, and Major Competitors
Table 87. Merck Major Business
Table 88. Merck β2 Adrenoceptor Agonists Product and Solutions
Table 89. Merck β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 90. Mylan Corporate Information, Head Office, and Major Competitors
Table 91. Mylan Major Business
Table 92. Mylan β2 Adrenoceptor Agonists Product and Solutions
Table 93. Mylan β2 Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 94. Global β2 Adrenoceptor Agonists Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 95. Global β2 Adrenoceptor Agonists Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 96. Breakdown of β2 Adrenoceptor Agonists by Company Type (Tier 1, Tier 2 and Tier 3)
Table 97. β2 Adrenoceptor Agonists Players Head Office, Products and Services Provided
Table 98. β2 Adrenoceptor Agonists Mergers & Acquisitions in the Past Five Years
Table 99. β2 Adrenoceptor Agonists New Entrants and Expansion Plans
Table 100. Global β2 Adrenoceptor Agonists Revenue (USD Million) by Type (2017-2022)
Table 101. Global β2 Adrenoceptor Agonists Revenue Share by Type (2017-2022)
Table 102. Global β2 Adrenoceptor Agonists Revenue Forecast by Type (2023-2028)
Table 103. Global β2 Adrenoceptor Agonists Revenue by Application (2017-2022)
Table 104. Global β2 Adrenoceptor Agonists Revenue Forecast by Application (2023-2028)
Table 105. North America β2 Adrenoceptor Agonists Revenue by Type (2017-2022) & (USD Million)
Table 106. North America β2 Adrenoceptor Agonists Revenue by Type (2023-2028) & (USD Million)
Table 107. North America β2 Adrenoceptor Agonists Revenue by Application (2017-2022) & (USD Million)
Table 108. North America β2 Adrenoceptor Agonists Revenue by Application (2023-2028) & (USD Million)
Table 109. North America β2 Adrenoceptor Agonists Revenue by Country (2017-2022) & (USD Million)
Table 110. North America β2 Adrenoceptor Agonists Revenue by Country (2023-2028) & (USD Million)
Table 111. Europe β2 Adrenoceptor Agonists Revenue by Type (2017-2022) & (USD Million)
Table 112. Europe β2 Adrenoceptor Agonists Revenue by Type (2023-2028) & (USD Million)
Table 113. Europe β2 Adrenoceptor Agonists Revenue by Application (2017-2022) & (USD Million)
Table 114. Europe β2 Adrenoceptor Agonists Revenue by Application (2023-2028) & (USD Million)
Table 115. Europe β2 Adrenoceptor Agonists Revenue by Country (2017-2022) & (USD Million)
Table 116. Europe β2 Adrenoceptor Agonists Revenue by Country (2023-2028) & (USD Million)
Table 117. Asia-Pacific β2 Adrenoceptor Agonists Revenue by Type (2017-2022) & (USD Million)
Table 118. Asia-Pacific β2 Adrenoceptor Agonists Revenue by Type (2023-2028) & (USD Million)
Table 119. Asia-Pacific β2 Adrenoceptor Agonists Revenue by Application (2017-2022) & (USD Million)
Table 120. Asia-Pacific β2 Adrenoceptor Agonists Revenue by Application (2023-2028) & (USD Million)
Table 121. Asia-Pacific β2 Adrenoceptor Agonists Revenue by Region (2017-2022) & (USD Million)
Table 122. Asia-Pacific β2 Adrenoceptor Agonists Revenue by Region (2023-2028) & (USD Million)
Table 123. South America β2 Adrenoceptor Agonists Revenue by Type (2017-2022) & (USD Million)
Table 124. South America β2 Adrenoceptor Agonists Revenue by Type (2023-2028) & (USD Million)
Table 125. South America β2 Adrenoceptor Agonists Revenue by Application (2017-2022) & (USD Million)
Table 126. South America β2 Adrenoceptor Agonists Revenue by Application (2023-2028) & (USD Million)
Table 127. South America β2 Adrenoceptor Agonists Revenue by Country (2017-2022) & (USD Million)
Table 128. South America β2 Adrenoceptor Agonists Revenue by Country (2023-2028) & (USD Million)
Table 129. Middle East & Africa β2 Adrenoceptor Agonists Revenue by Type (2017-2022) & (USD Million)
Table 130. Middle East & Africa β2 Adrenoceptor Agonists Revenue by Type (2023-2028) & (USD Million)
Table 131. Middle East & Africa β2 Adrenoceptor Agonists Revenue by Application (2017-2022) & (USD Million)
Table 132. Middle East & Africa β2 Adrenoceptor Agonists Revenue by Application (2023-2028) & (USD Million)
Table 133. Middle East & Africa β2 Adrenoceptor Agonists Revenue by Country (2017-2022) & (USD Million)
Table 134. Middle East & Africa β2 Adrenoceptor Agonists Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. β2 Adrenoceptor Agonists Picture
Figure 2. Global β2 Adrenoceptor Agonists Revenue Market Share by Type in 2021
Figure 3. Albuterol
Figure 4. Terbutaline
Figure 5. Salmeterol
Figure 6. Formoterol
Figure 7. Pirbuterol
Figure 8. β2 Adrenoceptor Agonists Revenue Market Share by Application in 2021
Figure 9. Bronchial Asthma Picture
Figure 10. Asthmatic Bronchitis Picture
Figure 11. Emphysema Picture
Figure 12. Others Picture
Figure 13. Global β2 Adrenoceptor Agonists Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 14. Global β2 Adrenoceptor Agonists Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global β2 Adrenoceptor Agonists Revenue Market Share by Region (2017-2028)
Figure 16. Global β2 Adrenoceptor Agonists Revenue Market Share by Region in 2021
Figure 17. North America β2 Adrenoceptor Agonists Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Europe β2 Adrenoceptor Agonists Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Asia-Pacific β2 Adrenoceptor Agonists Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. South America β2 Adrenoceptor Agonists Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Middle East and Africa β2 Adrenoceptor Agonists Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. β2 Adrenoceptor Agonists Market Drivers
Figure 23. β2 Adrenoceptor Agonists Market Restraints
Figure 24. β2 Adrenoceptor Agonists Market Trends
Figure 25. Ivax Pharmaceuticals  Recent Developments and Future Plans
Figure 26. Physicians Total Care Recent Developments and Future Plans
Figure 27. Baxter Healthcare  Recent Developments and Future Plans
Figure 28. Sanofi Recent Developments and Future Plans
Figure 29. Pfizer Recent Developments and Future Plans
Figure 30. Bedford Laboratories Recent Developments and Future Plans
Figure 31. Novartis Recent Developments and Future Plans
Figure 32. Sterimax Recent Developments and Future Plans
Figure 33. Teligent Recent Developments and Future Plans
Figure 34. AstraZeneca Recent Developments and Future Plans
Figure 35. Hikma Pharmaceuticals Recent Developments and Future Plans
Figure 36. Av Kare Recent Developments and Future Plans
Figure 37. Impax Laboratories Recent Developments and Future Plans
Figure 38. PD-Rx Pharmaceuticals Recent Developments and Future Plans
Figure 39. Athenex Pharmaceutical Division Recent Developments and Future Plans
Figure 40. Teva Recent Developments and Future Plans
Figure 41. Marlex Pharmaceuticals Recent Developments and Future Plans
Figure 42. Lannett Company Recent Developments and Future Plans
Figure 43. West-Ward Pharmaceuticals Recent Developments and Future Plans
Figure 44. United Biomedical Recent Developments and Future Plans
Figure 45. Merck Recent Developments and Future Plans
Figure 46. Mylan Recent Developments and Future Plans
Figure 47. Global β2 Adrenoceptor Agonists Revenue Share by Players in 2021
Figure 48. β2 Adrenoceptor Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 49. Global Top 3 Players β2 Adrenoceptor Agonists Revenue Market Share in 2021
Figure 50. Global Top 10 Players β2 Adrenoceptor Agonists Revenue Market Share in 2021
Figure 51. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 52. Global β2 Adrenoceptor Agonists Revenue Share by Type in 2021
Figure 53. Global β2 Adrenoceptor Agonists Market Share Forecast by Type (2023-2028)
Figure 54. Global β2 Adrenoceptor Agonists Revenue Share by Application in 2021
Figure 55. Global β2 Adrenoceptor Agonists Market Share Forecast by Application (2023-2028)
Figure 56. North America β2 Adrenoceptor Agonists Sales Market Share by Type (2017-2028)
Figure 57. North America β2 Adrenoceptor Agonists Sales Market Share by Application (2017-2028)
Figure 58. North America β2 Adrenoceptor Agonists Revenue Market Share by Country (2017-2028)
Figure 59. United States β2 Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Canada β2 Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Mexico β2 Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Europe β2 Adrenoceptor Agonists Sales Market Share by Type (2017-2028)
Figure 63. Europe β2 Adrenoceptor Agonists Sales Market Share by Application (2017-2028)
Figure 64. Europe β2 Adrenoceptor Agonists Revenue Market Share by Country (2017-2028)
Figure 65. Germany β2 Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. France β2 Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. United Kingdom β2 Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Russia β2 Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Italy β2 Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Asia-Pacific β2 Adrenoceptor Agonists Sales Market Share by Type (2017-2028)
Figure 71. Asia-Pacific β2 Adrenoceptor Agonists Sales Market Share by Application (2017-2028)
Figure 72. Asia-Pacific β2 Adrenoceptor Agonists Revenue Market Share by Region (2017-2028)
Figure 73. China β2 Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Japan β2 Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Korea β2 Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. India β2 Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Southeast Asia β2 Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Australia β2 Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South America β2 Adrenoceptor Agonists Sales Market Share by Type (2017-2028)
Figure 80. South America β2 Adrenoceptor Agonists Sales Market Share by Application (2017-2028)
Figure 81. South America β2 Adrenoceptor Agonists Revenue Market Share by Country (2017-2028)
Figure 82. Brazil β2 Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Argentina β2 Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. Middle East and Africa β2 Adrenoceptor Agonists Sales Market Share by Type (2017-2028)
Figure 85. Middle East and Africa β2 Adrenoceptor Agonists Sales Market Share by Application (2017-2028)
Figure 86. Middle East and Africa β2 Adrenoceptor Agonists Revenue Market Share by Country (2017-2028)
Figure 87. Turkey β2 Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 88. Saudi Arabia β2 Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 89. UAE β2 Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 90. Methodology
Figure 91. Research Process and Data Source